Dr G Vamshi Krishna Reddy
The Best Oncologist Doctor
MD, DM (Medical Oncology)

Dr. G. Vamshi Krishna Reddy is an MD, DM (Medical Oncology) doctor and Director–Oncology Services, Consultant Medical Oncologist & Hemato Oncologist at Yashoda Hospitals, Malakpet, Hyderabad. His profile lists experience in chemotherapy, targeted therapy, immunotherapy, tumour board consultation and hematology services, with expertise including lung, breast, ovarian and colon cancers and hematological malignancies.

A medical oncologist diagnoses and manages cancer using systemic treatments such as chemotherapy, targeted therapy, immunotherapy and, where appropriate, hormone therapy. You may see one after a cancer diagnosis, when treatment needs to be planned, or when you need specialist advice about systemic cancer treatment.

Persistent unexplained symptoms such as an unusual lump, unexplained weight loss, abnormal bleeding, or a prolonged cough should be medically evaluated. Coughing blood, severe breathlessness, or sudden severe pain need same-day medical care rather than waiting for a routine appointment.

Ask about the exact cancer type and stage, the purpose of the proposed treatment, expected benefits and side effects, treatment duration, whether molecular or other additional tests are needed, and what alternatives may be appropriate. Bring pathology reports, biopsy results, scans, blood-test reports and a list of current medicines.

Diagnosis may involve medical history and examination, imaging such as CT, MRI or PET scans when appropriate, blood tests, and a biopsy or other tissue/cell testing. The exact work-up depends on the suspected cancer and the findings from earlier tests.

Modern cancer care may include chemotherapy, targeted therapy, immunotherapy, hormone therapy, surgery and radiation therapy, depending on the cancer. Targeted therapy is used when a tumour has a relevant molecular target; immunotherapy helps the immune system recognize and attack cancer cells and is used for selected cancers and situations. Dr. G. Vamshi Krishna Reddy's verified profile lists chemotherapy, targeted therapy, immunotherapy, tumour board consultation and hematology services.

Treatment response may be assessed using symptoms, physical examination, blood tests, tumour markers where appropriate, and imaging such as CT or PET scans. The timing and type of assessment depend on the cancer and the treatment being given.

A second opinion can be useful when you want to confirm the diagnosis or stage, review pathology or molecular results, or discuss whether surgery, radiation, chemotherapy, targeted therapy, immunotherapy or a clinical trial should be considered. It is especially reasonable when the diagnosis or treatment plan is complex or you are uncertain about the recommended approach.

The plan starts with confirming the lung cancer type, stage and pathology. For non-small cell lung cancer, staging generally uses the TNM system and is grouped into stages I through IV; small cell lung cancer is commonly described as limited-stage or extensive-stage disease. Doctors also consider molecular results, overall health and treatment goals before selecting surgery, radiation, chemotherapy, targeted therapy, immunotherapy or combinations.

For non-small cell lung cancer, commonly considered biomarkers can include EGFR, ALK, ROS1, BRAF and other actionable alterations, along with PD-L1 testing. Testing is generally performed on biopsy/tumour tissue and, when appropriate, may also use a blood-based test. The exact panel should be confirmed by the treating oncologist and pathology team because testing depends on the cancer subtype and clinical situation.

Lung cancer evaluation may include chest imaging, laboratory tests and a biopsy to establish the diagnosis. Symptoms that should prompt evaluation include a cough lasting more than 3 weeks, coughing blood, unexplained weight loss and breathlessness; this is particularly important for people who smoke or have a significant smoking history. As a general guide, diagnosis may take several days to a couple of weeks when routine imaging and biopsy are completed; it can take longer when additional molecular or specialized tests are required. Actual timing varies by case and laboratory turnaround.

The specialist will review your symptoms, medical history, smoking history where relevant, pathology or biopsy reports, scans and other test results. The discussion may cover the cancer type and stage, whether molecular testing is needed, treatment options, treatment goals, expected side effects and the next tests or treatment steps.

The oncologist confirms the treatment protocol, reviews blood counts and other relevant tests, monitors response and side effects, and adjusts treatment when clinically necessary. Supportive medicines may be used to prevent or control side effects such as nausea, and the oncology team gives instructions about symptoms that require urgent contact.

Selection depends on the cancer type and stage, pathology, molecular or biomarker results where relevant, previous treatments, overall health, organ function, expected benefits and potential risks. For some cancers, chemotherapy is combined with targeted therapy, immunotherapy, surgery or radiation depending on the treatment plan.

Before treatment, confirm the medicines being given, the purpose of treatment, the schedule and expected duration, common side effects, medicines to take at home, food and activity instructions, and who to contact after hours. Ask the oncology team what symptoms require urgent assessment and keep the team's contact number available.

Many outpatient chemotherapy infusions take roughly 1–4 hours, but the total visit can be shorter or much longer depending on the medicines, pre-medications, hydration, monitoring and protocol. Some treatments require prolonged or repeated infusions. The oncology team should confirm the expected duration for the specific regimen before each cycle.

Common side effects can include nausea or vomiting, fatigue, hair loss, low blood counts, mouth ulcers and changes in appetite or bowel habits. Management may include anti-nausea medicines, mouth care, hydration, blood-count monitoring and treatment adjustments when needed. Fever of 38°C (100.4°F) or higher, chills, uncontrolled vomiting or diarrhoea, unusual or significant bleeding, severe breathlessness or chest pain during or after chemotherapy need urgent contact with the oncology team or emergency care. Patients should ask their doctor to confirm the exact thresholds and the emergency/after-hours contact number for their treatment plan.